共 50 条
- [41] Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial LANCET ONCOLOGY, 2016, 17 (01): : 48 - 56
- [44] Intravenous immunoglobulins (ivig) for relapses of Anca-associated systemic vasculitides: Final analysis of a prospective, open and multicenter trial. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S649 - S649